MARKET DEFINITION

Environmental changes are caused by biological chemicals and biological processes. Due to its potential effects, the use of bone replacement materials, and greater awareness of the rapidly aging population, bio-pharmacy is becoming a more crucial component of spinal fusion. In many spinal procedures, spinal devices are employed to manage problems such as deformities, disc degeneration, and fractures. In contrast to inert metals, which do not affect cell function or drive cell development, they actively boost bone production and promote spinal fusion.

MARKET DYNAMICS

Spinal procedures have increased as a result of the rise in spinal disorders, which is also driving up demand for spinal devices. Degenerative disc degeneration and congenital abnormalities are the main causes of spinal operations. The market for spinal devices and biologics is expected to develop due to the increase in less invasive surgery. However, the growth of businesses is hampered by high price problems and unfair compensation practices. As a result, a lack of patient education may result in a lower acceptance rate for these devices, which in turn may slow the market growth for spinal devices and biologics. Furthermore, the market for spinal devices and biologics is being significantly impacted by the growth of the artificial intelligence industry. The more 3D-printed implants are used, the better the procedures will be. The driving factors of market growth opportunities are the rising senior population and the comorbidities that go along with it.

REPORT SCOPE

The report titled “Global Spinal Devices and Biologics Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Spinal Devices and Biologics market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Spinal Devices and Biologics market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Spinal Devices and Biologics Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW 

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

 

MARKET SEGMENTATION

The Global Spinal Devices and Biologics Market is segmented based on type, disease indication, End-user, and region. Based on type, the market has been segmented into Fusion Devices (Cervical, Thoracolumbar, Interbody, and Biologics) and Non-Fusion Devices (Vertebral compression fracture devices, Artificial discs, Dynamic stabilization devices, and Others whereas based on disease indication, the market comprises Degenerative Disc Disease, Complex Deformity, Traumas and Fractures, and Others. Based on end-user, the market has been segmented into Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Spinal Devices and Biologics market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Spinal Devices and Biologics market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Spinal Devices and Biologics market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Spinal Devices and Biologics industry in the past three years.

Key players in the Global Spinal Devices and Biologics Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

·         Exactech, Inc.

·         Zimmer Biomet

·         Medtronic

·         Globus Medical

·         Integra LifeSciences

·         NuVasive, Inc.

·         Stryker

·         Orthofix US LLC

·         Wright Medical Group N.V.

·         Smith+Nephew

·         ZAVATION

COVID-19 IMPACT ANALYSIS ON GLOBAL SPINAL DEVICES AND BIOLOGICS MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

 

Report Attribute/Metric	Details
Market Size	In USD Million
CAGR	In % (2022-2028)
Base Year	2021
Forecast Period	2022 – 2028
Historical Data	2017 to 2021
Forecast Unit	Value (US$ Mn)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors and Trends
Geographies Covered	North America, Europe, Asia-Pacific, South America, and Middle East & Africa
Key Players Analyzed	Exactech, Inc., Zimmer Biomet, Medtronic, Globus Medical, Integra LifeSciences, NuVasive, Inc., Stryker, Orthofix US LLC, Wright Medical Group N.V., Smith+Nephew, and ZAVATION
Customization & Pricing	Available on Request (10% Customization is Free)

 

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1.    What is the current size of the global Spinal Devices and Biologics market?

2.    What will be the growth rate of the market over the forecast period?

3.    Who are the key manufacturers/vendors in the Spinal Devices and Biologics market space?

4.    What are the major market opportunities and market risks faced by the market?

5.    What is the impact of COVID-19 on the market?

6.    What are the revenue, sales, and price analysis of the top manufacturers in this market?

7.    What are the key outcomes of Porter's five forces model?

8.    Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

·         The report offers comprehensive data on the Spinal Devices and Biologics market elaborating on the current state and future growth prospects both globally and regionally

·         It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth

·         The report offers deep-dive insights into each market segment and critical factors responsible for its growth

·         The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position

·         The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions

·         Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope

·         The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

 

Chapter 1.  Executive Summary

1.1.   Market Outlook

1.2.   Market Segment Outlook

1.3.   Geography Outlook

1.4.   Absolute $ Opportunity

Chapter 2.  Research Methodology

2.1.   Research Approach

2.2.   Scope, Definition, and Assumptions

2.3.   Data Sources

2.3.1. Secondary Sources

2.3.1.1.         Preliminary Data Mining

2.3.2. Primary Sources

2.3.2.1.         Statistical End-user

2.3.2.2.         Data Triangulation

2.3.2.3.         Research Objective

Chapter 3.  Market Outlook

3.1.   Introduction

3.2.   Key Trends

3.2.1. Type Trends

3.2.2. Disease Indication Trends

3.2.3. End-user Trends

3.3.   Market Dynamics

3.3.1. Market Drivers

3.3.1.1.         Impact Analysis of Market Drivers

3.3.2. Market Restraints

3.3.2.1.         Impact Analysis of Market Restraints

3.3.3. Market Opportunities

3.3.3.1.         Impact Analysis of Market Opportunities

3.3.4. Market Challenges

3.3.4.1.         Impact Analysis of Market Challenges

3.4.   Porter’s Five Forces’ Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of New Entrant

3.4.4. Threat of Substitutes

3.4.5. Competitive Rivalry

3.5.   Value Chain Analysis: Global Spinal Devices and Biologics Market

3.6.   COVID-19 Impact Assessment in Spinal Devices and Biologics Market

3.6.1. Impact Assessment on Global Spinal Devices and Biologics Market

3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4.  Global Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

4.1.   Global Spinal Devices and Biologics Market Share, By Type, 2017 - 2028 (USD Million)

4.1.1. Fusion Devices

4.1.1.1.         Cervical

4.1.1.2.         Thoracolumbar

4.1.1.3.         Interbody

4.1.1.4.         Biologics

4.1.2. Non-Fusion Devices

4.1.2.1.         Vertebral compression fracture devices

4.1.2.2.         Artificial discs

4.1.2.3.         Dynamic stabilization devices

4.1.2.4.         Others

Chapter 5.  Global Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

5.1.   Global Spinal Devices and Biologics Market Share, By Disease Indication, 2017 - 2028 (USD Million)

5.1.1. Degenerative Disc Disease

5.1.2. Complex Deformity

5.1.3. Traumas and Fractures

5.1.4. Others     

Chapter 6.  Global Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

6.1.   Global Spinal Devices and Biologics Market Share, By End-user, 2017 - 2028 (USD Million)

6.1.1. Hospitals

6.1.2. Ambulatory Surgery Centers

6.1.3. Specialty Clinics

6.1.4. Others

Chapter 7.  Global Spinal Devices and Biologics Market Overview, By Geography, 2017 - 2028 (USD Million)

7.1.   Global Spinal Devices and Biologics Market Share, By Geography, 2017 - 2028 (USD Million)

7.1.1. Market Deployment and Projections, by Countries, 2017 - 2028 (USD Million)

7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8.  North America Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

8.1.     North America Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

8.1.1.     Market Deployment and Projections, 2017 - 2028 (USD Million)

8.1.2.     North America Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

8.1.3.     North America Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

8.1.4.     North America Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

8.2.     North America Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

8.2.1.     U.S. Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

8.2.1.1.         U.S. Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

8.2.1.2.         U.S. Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

8.2.1.3.         U.S. Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

8.2.2.     Canada Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

8.2.2.1.         Canada Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

8.2.2.2.         Canada Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

8.2.2.3.         Canada Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

8.2.3.     Mexico Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

8.2.3.1.         Mexico Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

8.2.3.2.         Mexico Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

8.2.3.3.         Mexico Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 9.  Europe Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

9.1.     Europe Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.1.1. Market Deployment and Projections, 2017 - 2028 (USD Million)

9.1.2.     Europe Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.1.3.     Europe Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.1.4.     Europe Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.     Europe Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

9.2.1.     Germany Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.1.1.         Germany Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.1.2.         Germany Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.1.3.         Germany Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.2.     France Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.2.1.         France Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.2.2.         France Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.2.3.         France Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.3.     UK Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.3.1.         UK Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.3.2.         UK Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.3.3.         UK Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.4.     Italy Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.4.1.         Italy Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.4.2.         Italy Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.4.3.         Italy Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.5.     Spain Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.5.1.         Spain Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.5.2.         Spain Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.5.3.         Spain Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.6.     NORDIC Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.6.1.         NORDIC Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.6.2.         NORDIC Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.6.3.         NORDIC Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.7.     Russia and CIS Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.7.1.         Russia and CIS Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.7.2.         Russia and CIS Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.7.3.         Russia and CIS Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

9.2.8.     Rest of Europe Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

9.2.8.1.         Rest of Europe Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

9.2.8.2.         Rest of Europe Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

9.2.8.3.         Rest of Europe Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 10.      Asia Pacific Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

10.1.  Asia Pacific Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.1.1.   Market Deployment and Projections, 2017 - 2028 (USD Million)

10.1.2.   Asia Pacific Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.1.3.   Asia Pacific Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.1.4.   Asia Pacific Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.  Asia Pacific Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

10.2.1.   India Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.1.1.       India Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.1.2.       India Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.1.3.       India Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.2.   China Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.2.1.       China Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.2.2.       China Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.2.3.       China Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.3.   Japan Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.3.1.       Japan Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.3.2.       Japan Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.3.3.       Japan Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.4.   ASEAN Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.4.1.       ASEAN Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.4.2.       ASEAN Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.4.3.       ASEAN Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.5.   South Korea Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.5.1.       South Korea Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.5.2.       South Korea Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.5.3.       South Korea Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.6.   Australia Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.6.1.       Australia Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.6.2.       Australia Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.6.3.       Australia Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

10.2.7.   Rest of Asia Pacific Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

10.2.7.1.       Rest of Asia Pacific Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

10.2.7.2.       Rest of Asia Pacific Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

10.2.7.3.       Rest of Asia Pacific Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 11.      South America Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

11.1.  South America Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

11.1.1.   Market Deployment and Projections, 2017 - 2028 (USD Million)

11.1.2.   South America Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

11.1.3.   South America Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

11.1.4.   South America Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.  South America Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

11.2.1.   Brazil Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

11.2.1.1.       Brazil Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

11.2.1.2.       Brazil Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

11.2.1.3.       Brazil Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.2.   Argentina Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

11.2.2.1.       Argentina Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

11.2.2.2.       Argentina Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

11.2.2.3.       Argentina Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

11.2.3.   Rest of South America Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

11.2.3.1.       Rest of South America Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

11.2.3.2.       Rest of South America Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

11.2.3.3.       Rest of South America Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 12.      Middle East & Africa Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

12.1.  Middle East & Africa Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

12.1.1.   Market Deployment and Projections, 2017 - 2028 (USD Million)

12.1.2.   Middle East & Africa Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

12.1.3.   Middle East & Africa Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

12.1.4.   Middle East & Africa Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.  Middle East & Africa Spinal Devices and Biologics Market Overview, By Countries, 2017 - 2028 (USD Million)

12.2.1.   GCC Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

12.2.1.1.       GCC Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

12.2.1.2.       GCC Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

12.2.1.3.       GCC Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.2.   South Africa Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

12.2.2.1.       South Africa Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

12.2.2.2.       South Africa Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

12.2.2.3.       South Africa Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

12.2.3.   Rest of Middle East & Africa Spinal Devices and Biologics Market Overview, 2017 - 2028 (USD Million)

12.2.3.1.       Rest of Middle East & Africa Spinal Devices and Biologics Market Overview, By Type, 2017 - 2028 (USD Million)

12.2.3.2.       Rest of Middle East & Africa Spinal Devices and Biologics Market Overview, By Disease Indication, 2017 - 2028 (USD Million)

12.2.3.3.       Rest of Middle East & Africa Spinal Devices and Biologics Market Overview, By End-user, 2017 - 2028 (USD Million)

Chapter 13.      Competitive Landscape

13.1.  Competitive Environment, 2021

13.2.  Strategic Framework

13.2.1.   Partnership/Collaborations/Agreement

13.2.2.   Expansion

13.2.3.   Mergers & Acquisitions

13.2.4.   New Product Development

Chapter 14.      Key Vendor Analysis

14.1.              Exactech, Inc.

14.1.1.       Business Overview

14.1.2.       Product Benchmarking

14.1.3.       Financial Data

14.1.4.       Strategic Overview

14.1.5.       Key Developments

14.1.6.       SWOT Analysis

14.2.              Zimmer Biomet

14.2.1.       Business Overview

14.2.2.       Product Benchmarking

14.2.3.       Financial Data

14.2.4.       Strategic Overview

14.2.5.       Key Developments

14.2.6.       SWOT Analysis

14.3.              Medtronic

14.3.1.       Business Overview

14.3.2.       Product Benchmarking

14.3.3.       Financial Data

14.3.4.       Strategic Overview

14.3.5.       Key Developments

14.3.6.       SWOT Analysis

14.4.              Globus Medical

14.4.1.       Business Overview

14.4.2.       Product Benchmarking

14.4.3.       Financial Data

14.4.4.       Strategic Overview

14.4.5.       Key Developments

14.4.6.       SWOT Analysis

14.5.              Integra LifeSciences

14.5.1.       Business Overview

14.5.2.       Product Benchmarking

14.5.3.       Financial Data

14.5.4.       Strategic Overview

14.5.5.       Key Developments

14.5.6.       SWOT Analysis

14.6.              NuVasive, Inc.

14.6.1.       Business Overview

14.6.2.       Product Benchmarking

14.6.3.       Financial Data

14.6.4.       Strategic Overview

14.6.5.       Key Developments

14.6.6.       SWOT Analysis

14.7.              Stryker

14.7.1.       Business Overview

14.7.2.       Product Benchmarking

14.7.3.       Financial Data

14.7.4.       Strategic Overview

14.7.5.       Key Developments

14.7.6.       SWOT Analysis

14.8.              Orthofix US LLC

14.8.1.       Business Overview

14.8.2.       Product Benchmarking

14.8.3.       Financial Data

14.8.4.       Strategic Overview

14.8.5.       Key Developments

14.8.6.       SWOT Analysis

14.9.              Wright Medical Group N.V.

14.9.1.       Business Overview

14.9.2.       Product Benchmarking

14.9.3.       Financial Data

14.9.4.       Strategic Overview

14.9.5.       Key Developments

14.9.6.       SWOT Analysis

14.10.            Smith+Nephew

14.10.1.    Business Overview

14.10.2.    Product Benchmarking

14.10.3.    Financial Data

14.10.4.    Strategic Overview

14.10.5.    Key Developments

14.10.6.    SWOT Analysis

14.11.            ZAVATION

14.11.1.    Business Overview

14.11.2.    Product Benchmarking

14.11.3.    Financial Data

14.11.4.    Strategic Overview

14.11.5.    Key Developments

14.11.6.    SWOT Analysis

Chapter 15.   Future Outlook of the Market